BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35593388)

  • 1. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.
    Wang M; Sun X; Xin H; Wen Z; Cheng Y
    Cancer Med; 2022 Dec; 11(23):4526-4543. PubMed ID: 35593388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway.
    Liu C; Ji J; Li C
    Am J Chin Med; 2024; 52(1):275-289. PubMed ID: 38291583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
    Deng H; Gong X; Ji G; Li C; Cheng S
    Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway.
    Jia Z; Xie Y; Wu H; Wang Z; Li A; Li Z; Yang Z; Zhang Z; Xing Z; Zhang X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
    Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.
    Katsha A; Arras J; Soutto M; Belkhiri A; El-Rifai W
    Mol Oncol; 2014 Dec; 8(8):1419-28. PubMed ID: 24953013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of JAK2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
    Yang G; Sheng B; Li R; Xu Q; Zhang L; Lu Z
    Anticancer Agents Med Chem; 2022; 22(9):1742-1752. PubMed ID: 34353270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway.
    Luo H; Yang Z; Zhang Q; Shao L; Wei S; Liu R; Li Z; Geng Y; Li C; Wang X
    Front Public Health; 2020; 8():579705. PubMed ID: 33330321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
    Liu JR; Wu WJ; Liu SX; Zuo LF; Wang Y; Yang JZ; Nan YM
    Pathol Res Pract; 2015 Jun; 211(6):426-34. PubMed ID: 25724470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
    Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
    J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Knockdown of Fez family zinc finger protein 1 antisense ribonucleic acid 1 (FEZF1-AS1) inhibits invasion and migration of esophageal squamous cell carcinoma cells by blocking JAK2/STAT3 pathway].
    Cao Y; Wang X; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):317-324. PubMed ID: 32519669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L; Xiao C; He K; Xiang G
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.